UniPharma Co., Ltd. (TPEX:6621)

UniPharma Revenue

UniPharma had revenue of 44.32M TWD in the half year ending June 30, 2025, a decrease of -12.51%. This brings the company's revenue in the last twelve months to 90.79M, down -8.81% year-over-year. In the year 2024, UniPharma had annual revenue of 93.46M, down -9.46%.

• Revenue (ttm): 90.79M
• Revenue Growth: -8.81%
• P/S Ratio: 4.69
• Revenue / Employee: 2.93M
• Employees: 31
• Market Cap: 426.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	93.46M	-9.77M	-9.46%
Dec 31, 2023	103.22M	-24.89M	-19.43%
Dec 31, 2022	128.11M	22.72M	21.56%
Dec 31, 2021	105.39M	-33.25M	-23.98%
Dec 31, 2020	138.64M	-15.64M	-10.14%